A phase II study of sacituzumab govitecan for advanced esophageal squamous cell carcinoma patients (SG-ESCC).

Authors: Jhe-Cyuan Guo, Tsung-Che Wu, Ta-Chen Huang, Hung-Yang Kuo, Chien-Huai Chuang, Wei-Chen Lu, Chia-Chi Lin, Chih-Hung Hsu

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps4208

Source: Full article

---

Abstract

TPS4208